Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Do my FASTQC results indicate sequencing bias?

    Hello,
    I used the Illumina Nextera Flex kit to sequence bacteria (WGS) and I got two warning that I usually do not get when using Nextera XT:

    1. overrepresented sequences in the first read (R1) but not the second read (R2).

    2. warning/error k-mer content

    Why do I get such errors? Does this indicate sequencing bias?
    Attached Files

  • #2
    This data must have been sequenced on NextSeq (or NovaSeq). That string of "G" is probably no-signal which is interpreted as G base.

    The bias at the beginning of the reads is likely due to the Nextera transposase sequence bias (similar to bias seen in "random priming") .

    If these are the only two "issues" then your data looks ok. Proceed with your normal analysis.

    Comment


    • #3
      Thank you for helping me!
      We use a MiseQ and it was the first time that we used Nextera Flex instead of XT. And it`s also the first time we got such a string of G.

      Beside these issues, I also got a warning for "per base sequence content". However, using Nextera XT always gives such issues.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Today, 06:25 AM
      0 responses
      13 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, Yesterday, 01:02 PM
      0 responses
      12 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-18-2024, 06:39 AM
      0 responses
      14 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-11-2024, 02:44 PM
      0 responses
      14 views
      0 likes
      Last Post seqadmin  
      Working...
      X